Evidence map›Paper›PMID 35681516›Full record

ArticleCells2022

Alveolar Basal Cells Differentiate towards Secretory Epithelial- and Aberrant Basaloid-like Cells In Vitro.

Petra Khan, Julien Roux, Sabrina Blumer, Lars Knudsen, Danny Jonigk, Mark P Kuehnel, Michael Tamm, Katrin E Hostettler

Open access · goldAbstract read
In one paragraph

Article in Cells, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
3.3field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 23 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Cytokine signaling converging onFrontiers in immunology · 2023
    Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 2 countries.

Petra KhanDepartment of Biomedicine and Clinics of Respiratory Medicine, University Hospital Basel, University of Basel, 4031 Basel, Switzerland.
Julien RouxDepartment of Biomedicine and Clinics of Respiratory Medicine, University Hospital Basel, University of Basel, 4031 Basel, Switzerland.ORCID 0000-0002-4192-5099
Sabrina BlumerDepartment of Biomedicine and Clinics of Respiratory Medicine, University Hospital Basel, University of Basel, 4031 Basel, Switzerland.
Lars KnudsenInstitute of Functional and Applied Anatomy, Hannover Medical School, 30625 Hannover, Germany.ORCID 0000-0002-7926-3879
Danny JonigkBiomedical Research in Endstage and Obstructive Lung Disease Hannover (BREATH), The German Center for Lung Research (DZL), 30625 Hannover, Germany.ORCID 0000-0002-5251-2281
Mark P KuehnelBiomedical Research in Endstage and Obstructive Lung Disease Hannover (BREATH), The German Center for Lung Research (DZL), 30625 Hannover, Germany.
Michael TammDepartment of Biomedicine and Clinics of Respiratory Medicine, University Hospital Basel, University of Basel, 4031 Basel, Switzerland.
Katrin E HostettlerDepartment of Biomedicine and Clinics of Respiratory Medicine, University Hospital Basel, University of Basel, 4031 Basel, Switzerland.
University of Basel · CHMedizinische Hochschule Hannover · DESIB Swiss Institute of Bioinformatics · CH

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

In idiopathic pulmonary fibrosis (IPF), keratin (KRT)17+/KRT5+ basal and KRT17+/KRT5- aberrant basaloid cells are atypically present within the alveolar space. We previously described the fibrosis-enriched outgrowth of alveolar basal cells from peripheral fibrotic lung tissue. Using single cell RNA sequencing (scRNA-seq), we here characterize the transcriptome of these cultured alveolar basal cells under different culture conditions.

methodsFibrotic peripheral lung tissue pieces were placed in DMEM growth medium. Outgrown cells were analysed by scRNA-seq, TaqMan-PCR or immunofluorescence (IF) either directly or after medium change to an epithelial cell specific medium (Cnt-PR-A).

resultsA fraction of alveolar basal cells cultured in DMEM growth medium showed close transcriptomic similarities to IPF basal cells. However, although they expressed KRT5, the transcriptome of the majority of cells matched best to the transcriptome of recently described KRT17+/KRT5- aberrant basaloid cells, co-expressing the canonical basal cell marker KRT17 and mesenchymal cell marker (VIM, FN1). A smaller fraction of cells matched best to secretory epithelial cells. Two differentiation gradients from basal to aberrant basaloid-like cells and basal to secretory epithelial-like cells were apparent. Interestingly, these differentiation paths seemed reversed when the cell culture medium was changed to Cnt-PR-A.

conclusionsOur results suggest that cultured alveolar basal cells have the capacity to differentiate towards secretory epithelial-like cells and to aberrant basaloid-like cells. However, due to the persistent expression of KRT5, a complete differentiation towards aberrant basaloid cells did not seem to be achieved in our culture conditions. Importantly, differentiation seemed reversible by changing the cells microenvironment. Determining specific factors influencing these differentiation paths may help to define novel drug targets for IPF therapy.

Indexed as

Alveolar Epithelial CellsIdiopathic Pulmonary FibrosisEpithelial CellsHumansLungTranscriptomeaberrant basaloid cellsalveolar epithelial cellsbasal cellsdifferentiationIPFsingle cell RNA sequencingtrans-differentiation

Identifiers

PMID35681516
PMCPMC9180703
OpenAlexW4281809745

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.